title: Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.
authors.forename: Alastair C J
authors.initials: AC
authors.lastname: Windsor
authors.forename: Richard
authors.initials: R
authors.lastname: Cohen
authors.forename: Long R
authors.initials: LR
authors.lastname: Jiao
authors.forename: Justin
authors.initials: J
authors.lastname: Stebbing
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab